Skip to main content
. 2019 Feb 26;10:236. doi: 10.3389/fimmu.2019.00236

Figure 1.

Figure 1

Autoantibodies in the sera of stroke patients react with BP180 and BP180-NC16A in immunoblotting. Serum antibodies from a patient with bullous pemphigoid (BP), a stroke patient (Stroke), or anti-human BP180 antibody (Control) but not a negative control serum (Negative) recognized a 180-kDa protein from human epidermal extract (A), the human recombinant full length BP180 (B), and human recombinant BP180-NC16A (C).